Good Morning Jane, you wrote:
> I am still having a hard time understanding what you are saying.
It is rather confusing, so perhaps the following excerpt from the
company's press release will help...
Monday April 27, 1998
Company Press Release
SOURCE: Medtronic, Inc.
Breakthrough Therapy from Medtronic Provides Freedom and Independence
from the Major Disabling Symptoms of Parkinson's Disease
MINNEAPOLIS, April 27 /PRNewswire/ -- Medtronic, Inc. (NYSE: MDT -
news), today announced the European commercial release (CE Mark
approval) of the most significant advance in the treatment of disabling
Parkinson's disease in more than 30 years. The new therapy, Activa(TM)
Parkinson's Control Therapy, involves mild electrical stimulation
deep within the brain and may provide Parkinson's sufferers relief from
the most profound symptoms of the disease and the serious side effects
induced by medications.
Activa Parkinson's Control Therapy builds on the success of the
Medtronic Activa(TM) Tremor Control Therapy, which is now used worldwide
and involves mild electrical stimulation of the thalamus to control
Essential Tremor and tremor associated with Parkinson's disease. The new
treatment involves stimulation of the globus pallidus or the subthalamic
regions of the brain to control the major symptoms of Parkinson's --
rigidity (stiffness or inflexibility of the limbs and joints),
bradykinesia/akinesia (slowness or absence of movement), postural
instability (impaired balance and coordination), in addition to tremor
(involuntary rhythmic shaking). Parkinson's Control Therapy is also
effective in controlling dyskinesias (abnormal, involuntary movement), a
side effect associated with antiparkinsonian drug therapy. <snip>
Also, the Medtronic web site provides a lot of interesting reading...
http://www.medtronic.com/
Judith
--
Judith Richards, London, Ontario, Canada
[log in to unmask]
